人妻少妇…嗯…啊…,日本免费观看mv免费版视频网站

熱門搜索化學(xué)品最多只顯示前20條，請點擊“搜索化學(xué)品”查看所有結(jié)果

CAS登錄號

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應(yīng)商

3163-31-3

Acetamide,N-[4-[[(2,6-dimethyl-4-pyrimidinyl)amino]sulfonyl]phenyl]-;
Acetanilide,4'-[(2,6-dimethyl-4-pyrimidinyl)sulfamoyl]- (6CI,7CI,8CI);
4N-Acetylsulfaisodimidine;
N4-AcetylsulfASOMidine;
N4-Acetylsulfisomidine

磺胺二甲基異嘧啶

Benzenesulfonamide,4-amino-N-(2,6-dimethyl-4-pyrimidinyl)-;
Sulfanilamide,N1-(2,6-dimethyl-4-pyrimidinyl)- (8CI);
2,4-Dimethyl-6-sulfanilamidopyrimidine;
2,6-Dimethyl-4-sulfanilamidopyrimidine;
4-Sulfanilamido-2,6-dimethylpyrimidine;
4-[[(2,6-Dimethylpyrimidin-4-yl)amino]sulfonyl]aniline;
6-(4-Aminobenzenesulfonamido)-2,4-dimethylpyrimidine;
6-(Sulfanilamido)-2,4-dimethyl-1,3-diazine;
6-(p-Aminobenzenesulfonamido)-2,4-dimethylpyrimidine;
6-(p-Aminophenylsulfonamido)-2,4-dimethylpyrimidine;
6-Sulfanilamido-2,4-dimethylpyrimidine;
6-[(p-Aminobenzenesulfonyl)amino]-2,4-dimethylpyrimidine;
Aristamid;
Aristogyn;
Domain;
Domian;
Elcosin;
Elcosine;
Elkosil;
Elkosin;
Elkosine;
Elkozin;
Erycon;
Mefenal;
N1-(2,6-Dimethyl-4-pyrimidinyl)sulfanilamide;
Sulfadimetine;
Sulfaisodimerazine;
Sulfamethine;
SulfASOMidin;
SulfASOMidine;
Sulfisomidin;
Sulfisomidine;
SulphASOMidine;
Sulphisomidine

Benzenesulfonamide,4-amino-N-(2,6-dimethyl-4-pyrimidinyl)-, sodium salt (1:1);
Benzenesulfonamide,4-amino-N-(2,6-dimethyl-4-pyrimidinyl)-, monosodium salt (9CI);
Sodium,[N1-(2,6-dimethyl-4-pyrimidinyl)sulfanilamido]- (7CI);
Sulfanilamide,N1-(2,6-dimethyl-4-pyrimidinyl)-, monosodium salt (8CI);
Sulfanilamide,N1-(2,6-dimethyl-4-pyrimidinyl)-, sodium deriv. (6CI);
Sodium sulfamethine;
Sodium sulfASOMidine;
Sulfisomidine sodium

Benzenesulfonamide,4-amino-N-(3-methyl-5-isothiazolyl)-;
Sulfanilamide,N1-(3-methyl-5-isothiazolyl)- (6CI,7CI,8CI);
2132TH;
3-Methyl-5-sulfanilamidoisothiazole;
Amidozol;
Amidozole;
Bidizole;
N1-(3-Methyl-5-isothiazolyl)sulfanilamide;
NSC 139593;
Sulfamizole;
SulfASOMizol;
SulfASOMizole;
SulphASOMisole;
SulphASOMizole

Ergosta-2,24-dien-26-oicacid, 6,7-epoxy-5,20,22,27-tetrahydroxy-1-oxo-, d-lactone, (5a,6a,7a,22R)-;
WithASOMniferolA

Ergosta-1,4,24-trien-26-oicacid, 22,27-dihydroxy-3-oxo-, d-lactone, (22R)- (9CI);
WithASOMidienone

Glycine,L-tyrosyl-L-prolyl-L-phenylalanyl-L-prolyl-;
Glycine,N-[1-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-prolyl]-;
16: PN: WO2005027953PAGE: 32 unclaimed sequence;
21: PN: WO2007025286 SEQID: 20 unclaimed sequence;
27: PN: WO0210195 PAGE: 63 claimed sequence;
3: PN: EP969015 SEQID: 3 claimedprotein;
622: PN: US20090175821 SEQID: 750 claimed protein;
94: PN: WO0069900SEQID: 750 unclaimed sequence;
95: PN: WO0069900 SEQID: 751 unclaimed sequence;
96: PN: WO0069900 SEQID: 752 unclaimed sequence;
Bovine b-cASOMorphin(1-5);
Tyr-Pro-Phe-Pro-Gly-OH;
b-CASOMorphin-5;
b-CASOMorphin-5 (ox)

Glycine,N-[1-[N-(1-L-tyrosyl-L-prolyl)-L-tryptophyl]-L-prolyl]- (9CI);
cASOMorphin, Trp(3)-

L-Isoleucine, L-tyrosyl-L-prolyl-L-phenylalanyl-L-valyl-L-a-glutamyl-L-prolyl-;
L-Isoleucine, N-[1-[N-[N-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-valyl]-L-a-glutamyl]-L-prolyl]-;
17: PN:WO2006017688 SEQID: 65 unclaimed sequence;
18: PN: WO0239997 SEQID: 23unclaimed sequence;
49: PN: WO2006068768 SEQID: 47 claimed sequence;
619: PN:US20090175821 SEQID: 745 claimed protein;
91: PN: WO0069900 SEQID: 745unclaimed sequence;
97: PN: WO0069900 SEQID: 753 unclaimed sequence;
Human b-cASOMorphin 7;
b-CASOMorphin (human);
b-CASOMorphin-7(human)

L-Prolinamide,L-tyrosyl-L-prolyl-L-valyl- (9CI);
H-TYR-PRO-VAL-PRO-NH2 ACETATE SALT;
H-TYR-PRO-VAL-PRO-NH2 ACOH;
(VAL3)-BETA-CASOMORPHIN (1-4) AMIDE (BOVINE) ACETATE;
(VAL3)-BETA-CASOMORPHIN (1-4) AMIDE (BOVINE) ACETATE SALT;
H-Tyr-Pro-Val-Pro-NH2;
TYR-PRO-VAL-PRO AMIDE

L-Isoleucine,L-tyrosyl-L-prolyl-L-phenylalanyl-L-prolylglycyl-L-prolyl-;
L-Isoleucine,N-[1-[N-[1-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-prolyl]glycyl]-L-prolyl]-;
13: PN: WO2005097158 SEQID: 13 unclaimed sequence;
14: PN: WO2004075843 PAGE: 5unclaimed sequence;
14: PN: WO2005027953 PAGE: 32 unclaimed sequence;
16: PN:WO2007025286 SEQID: 15 unclaimed sequence;
1: PN: EP969015 SEQID: 1 claimedprotein;
2651: PN: RU2206573 TABLE: 1 claimed sequence;
48: PN: WO2009012472SEQID: 48 unclaimed sequence;
620: PN: US20090175821 SEQID: 748 claimedprotein;
6: PN: CN1566152 PAGE: 4 unclaimed sequence;
92: PN: WO0069900 SEQID:748 unclaimed sequence;
Bovine b-cASOMorphin-7;
b-CASOMorphin (cattle);
b-CASOMorphin-7 (cattle);
b-CASOMorphin-7 (ox)

L-Phenylalanine,L-tyrosyl-L-prolyl-L-phenylalanyl-L-prolyl-L-prolyl- (9CI);
L-Phenylalanine,N-[1-[1-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-prolyl]-L-prolyl]-;
CASOMokinin F

L-Prolinamide,L-tyrosyl-D-alanyl-4-chloro-L-phenylalanyl- (9CI);
[D-ALA2, P-CHLORO-PHE3]-BETA-CASOMORPHIN (1-4) AMIDE (BOVINE);
[DALA2, (PCL)PHE3] BETA-CASOMORPHIN, AMIDE, BOVINE;
TYR-D-ALA-P-CHLORO-PHE-PRO-NH2;
TYR-DALA-(PCL)PHE-PRO-NH2;
B-CASOMORPHIN (D-ALA2,PCL-PHE3)-FRAGMENT 1-4 AMIDE;
[D-Ala2, p-Cl-Phe3]-β-CASOMorphin fragment 1-4 Amide

L-Prolinamide,L-tyrosyl-L-prolyl-L-phenylalanyl-;
166: PN:US20030176421 PAGE: 54-55 claimed protein;
H-Tyr-Pro-Phe-Pro-NH2;
Morphiceptin;
b-CASOMorphin-4-NH2;
b-CASOMorphin-4-amide

L-Leucine,L-tyrosyl-L-prolyl-L-phenylalanyl-L-prolyl-L-prolyl-;
L-Leucine,N-[1-[1-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-prolyl]-L-prolyl]-;
231:PN: WO0069900 SEQID: 905 unclaimed sequence;
720: PN: US20090175821 SEQID: 905claimed protein;
CASOMokinin L

L-Proline,L-tyrosyl-L-prolyl-L-phenylalanyl-;
L-Proline,1-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-;
106: PN: WO0069900 SEQID: 769unclaimed sequence;
107: PN: WO0069900 SEQID: 770 unclaimed sequence;
12: PN:WO2005097158 SEQID: 12 unclaimed sequence;
13: PN: WO2004075843 PAGE: 5unclaimed sequence;
15: PN: WO2005027953 PAGE: 32 unclaimed sequence;
19: PN:WO2007025286 SEQID: 18 unclaimed sequence;
1: PN: US6447772 SEQID: 1 unclaimedsequence;
1: PN: WO0124816 SEQID: 1 unclaimed sequence;
224: PN: WO0069900SEQID: 898 unclaimed sequence;
2: PN: US20060183235 SEQID: 2 unclaimedsequence;
39: PN: WO2009012472 SEQID: 39 unclaimed sequence;
43: PN:WO2006068768 SEQID: 41 claimed sequence;
4: PN: EP969015 SEQID: 4 claimedprotein;
5: PN: WO0130371 TABLE: 1 unclaimed sequence;
621: PN: US20090175821SEQID: 749 claimed protein;
93: PN: WO0069900 SEQID: 749 unclaimed sequence;
9:PN: WO0130371 TABLE: 1 unclaimed sequence;
b-CASOMorphin-4;
b-CASOMorphin-4 (ox)

L-a-Glutamine,N-[(phenylmethoxy)carbonyl]-L-leucyl-L-leucyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-;
CBZ-LEU-LEU-GLU-AMC;
CARBOBENZOXY-L-LEUCYL-L-LEUCYL-L-GLUTAMIC-ACID-ALPHA-(4-METHYLCOUMARINYL)-7-AMIDE;
BENZYLOXYCARBONYL-L-LEUCYL-L-LEUCYL-L-GLUTAMIC ACID ALPHA-(4-METHYLCOUMARYL-7-AMIDE);
PROTEASOME SUBSTRATE II (FLUOROGENIC);
Z-LEU-LEU-GLU-7-AMIDO-4-METHYLCOUMARIN;
Z-LEU-LEU-GLU-7-AMINO-4-METHYLCOUMARIN;
Z-LEU-LEU-GLU-AMC;
Z-LEU-LEU-GLU-MCA